nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxepin—CYP1A2—Dacarbazine—sarcoma	0.0646	0.155	CbGbCtD
Doxepin—CYP3A4—Thiotepa—sarcoma	0.061	0.147	CbGbCtD
Doxepin—ABCB1—Dactinomycin—sarcoma	0.0489	0.118	CbGbCtD
Doxepin—ABCB1—Mitoxantrone—sarcoma	0.0438	0.105	CbGbCtD
Doxepin—CYP1A2—Etoposide—sarcoma	0.0316	0.0759	CbGbCtD
Doxepin—ABCB1—Vincristine—sarcoma	0.0301	0.0724	CbGbCtD
Doxepin—ABCB1—Etoposide—sarcoma	0.0276	0.0663	CbGbCtD
Doxepin—CYP3A4—Mitoxantrone—sarcoma	0.0262	0.063	CbGbCtD
Doxepin—ABCB1—Doxorubicin—sarcoma	0.0188	0.0452	CbGbCtD
Doxepin—CYP3A4—Vincristine—sarcoma	0.0181	0.0434	CbGbCtD
Doxepin—CYP2D6—Doxorubicin—sarcoma	0.0178	0.0426	CbGbCtD
Doxepin—CYP3A4—Etoposide—sarcoma	0.0166	0.0397	CbGbCtD
Doxepin—CYP3A4—Doxorubicin—sarcoma	0.0113	0.0271	CbGbCtD
Doxepin—CHRM3—muscle of abdomen—sarcoma	0.00915	0.093	CbGeAlD
Doxepin—HRH4—hematopoietic system—sarcoma	0.00531	0.054	CbGeAlD
Doxepin—HTR2A—pulmonary artery—sarcoma	0.0046	0.0468	CbGeAlD
Doxepin—HRH4—bone marrow—sarcoma	0.00341	0.0346	CbGeAlD
Doxepin—HTR2A—hindlimb—sarcoma	0.00278	0.0283	CbGeAlD
Doxepin—HTR2A—appendage—sarcoma	0.00239	0.0243	CbGeAlD
Doxepin—HRH2—hematopoietic system—sarcoma	0.00223	0.0227	CbGeAlD
Doxepin—HRH2—skin of body—sarcoma	0.00194	0.0197	CbGeAlD
Doxepin—CHRM5—skin of body—sarcoma	0.00185	0.0188	CbGeAlD
Doxepin—HRH2—cardiac atrium—sarcoma	0.00169	0.0172	CbGeAlD
Doxepin—ORM1—hematopoietic system—sarcoma	0.00157	0.016	CbGeAlD
Doxepin—HTR2B—myometrium—sarcoma	0.00154	0.0157	CbGeAlD
Doxepin—CHRM4—testis—sarcoma	0.00149	0.0152	CbGeAlD
Doxepin—HTR2A—endothelium—sarcoma	0.00144	0.0146	CbGeAlD
Doxepin—CYP2C9—mammary gland—sarcoma	0.00141	0.0143	CbGeAlD
Doxepin—SLC6A4—hematopoietic system—sarcoma	0.00134	0.0136	CbGeAlD
Doxepin—KCNH2—myometrium—sarcoma	0.00123	0.0125	CbGeAlD
Doxepin—ADRA2C—myometrium—sarcoma	0.00121	0.0123	CbGeAlD
Doxepin—HTR1A—hematopoietic system—sarcoma	0.00119	0.0121	CbGeAlD
Doxepin—HTR2B—smooth muscle tissue—sarcoma	0.00117	0.0119	CbGeAlD
Doxepin—HRH2—liver—sarcoma	0.00116	0.0118	CbGeAlD
Doxepin—HTR2B—skin of body—sarcoma	0.00115	0.0117	CbGeAlD
Doxepin—KCNH2—seminal vesicle—sarcoma	0.00111	0.0113	CbGeAlD
Doxepin—CYP2C19—hematopoietic system—sarcoma	0.00111	0.0113	CbGeAlD
Doxepin—ADRA2C—seminal vesicle—sarcoma	0.0011	0.0112	CbGeAlD
Doxepin—ADRA1A—hematopoietic system—sarcoma	0.00109	0.0111	CbGeAlD
Doxepin—KCNH2—hematopoietic system—sarcoma	0.00106	0.0107	CbGeAlD
Doxepin—CHRM3—smooth muscle tissue—sarcoma	0.00105	0.0107	CbGeAlD
Doxepin—ORM1—bone marrow—sarcoma	0.00101	0.0102	CbGeAlD
Doxepin—HTR2B—uterus—sarcoma	0.001	0.0102	CbGeAlD
Doxepin—HRH1—myometrium—sarcoma	0.000986	0.01	CbGeAlD
Doxepin—ADRA2A—myometrium—sarcoma	0.000968	0.00985	CbGeAlD
Doxepin—CYP1A2—hematopoietic system—sarcoma	0.000904	0.0092	CbGeAlD
Doxepin—HRH2—lymph node—sarcoma	0.000886	0.00901	CbGeAlD
Doxepin—HTR2B—tendon—sarcoma	0.000876	0.00891	CbGeAlD
Doxepin—ADRA2A—seminal vesicle—sarcoma	0.000875	0.0089	CbGeAlD
Doxepin—CYP2C9—hematopoietic system—sarcoma	0.000858	0.00873	CbGeAlD
Doxepin—HRH1—hematopoietic system—sarcoma	0.000847	0.00861	CbGeAlD
Doxepin—ADRA2A—hematopoietic system—sarcoma	0.000832	0.00846	CbGeAlD
Doxepin—HRH1—connective tissue—sarcoma	0.000815	0.00829	CbGeAlD
Doxepin—ORM1—liver—sarcoma	0.000812	0.00826	CbGeAlD
Doxepin—KCNH2—cardiac atrium—sarcoma	0.000802	0.00816	CbGeAlD
Doxepin—ADRA2A—connective tissue—sarcoma	0.000801	0.00814	CbGeAlD
Doxepin—KCNH2—uterus—sarcoma	0.000798	0.00812	CbGeAlD
Doxepin—HTR2A—embryo—sarcoma	0.000792	0.00806	CbGeAlD
Doxepin—ADRA2C—cardiac atrium—sarcoma	0.000791	0.00805	CbGeAlD
Doxepin—ADRA2C—uterus—sarcoma	0.000787	0.00801	CbGeAlD
Doxepin—ADRA1A—lymphoid tissue—sarcoma	0.00077	0.00783	CbGeAlD
Doxepin—HRH1—smooth muscle tissue—sarcoma	0.000746	0.00758	CbGeAlD
Doxepin—HTR2A—hematopoietic system—sarcoma	0.000707	0.00719	CbGeAlD
Doxepin—ADRA2C—tendon—sarcoma	0.00069	0.00702	CbGeAlD
Doxepin—HTR2A—connective tissue—sarcoma	0.000681	0.00692	CbGeAlD
Doxepin—KCNH2—bone marrow—sarcoma	0.000677	0.00689	CbGeAlD
Doxepin—CYP3A4—hematopoietic system—sarcoma	0.000655	0.00666	CbGeAlD
Doxepin—CHRM3—testis—sarcoma	0.000653	0.00664	CbGeAlD
Doxepin—SLC6A2—testis—sarcoma	0.000645	0.00656	CbGeAlD
Doxepin—CYP2D6—hematopoietic system—sarcoma	0.000644	0.00655	CbGeAlD
Doxepin—ADRA2A—cardiac atrium—sarcoma	0.000631	0.00642	CbGeAlD
Doxepin—ADRA2A—uterus—sarcoma	0.000628	0.00639	CbGeAlD
Doxepin—ORM1—lymph node—sarcoma	0.000623	0.00634	CbGeAlD
Doxepin—HTR2A—smooth muscle tissue—sarcoma	0.000623	0.00633	CbGeAlD
Doxepin—DRD2—testis—sarcoma	0.000587	0.00598	CbGeAlD
Doxepin—KCNH2—testis—sarcoma	0.000579	0.00589	CbGeAlD
Doxepin—CYP2C19—liver—sarcoma	0.000574	0.00583	CbGeAlD
Doxepin—ADRA2C—testis—sarcoma	0.000571	0.00581	CbGeAlD
Doxepin—ADRA1A—liver—sarcoma	0.000567	0.00576	CbGeAlD
Doxepin—HRH1—tendon—sarcoma	0.00056	0.0057	CbGeAlD
Doxepin—ADRA2A—tendon—sarcoma	0.00055	0.0056	CbGeAlD
Doxepin—ADRA2C—liver—sarcoma	0.00054	0.00549	CbGeAlD
Doxepin—ABCB1—myometrium—sarcoma	0.00054	0.00549	CbGeAlD
Doxepin—HTR2B—lymph node—sarcoma	0.000526	0.00535	CbGeAlD
Doxepin—ABCB1—embryo—sarcoma	0.000519	0.00528	CbGeAlD
Doxepin—ABCB1—seminal vesicle—sarcoma	0.000487	0.00496	CbGeAlD
Doxepin—Influenza—Doxorubicin—sarcoma	0.000477	0.00104	CcSEcCtD
Doxepin—Pollakiuria—Epirubicin—sarcoma	0.000476	0.00103	CcSEcCtD
Doxepin—Hypersensitivity—Vincristine—sarcoma	0.000476	0.00103	CcSEcCtD
Doxepin—Eosinophilia—Doxorubicin—sarcoma	0.000472	0.00102	CcSEcCtD
Doxepin—Paraesthesia—Etoposide—sarcoma	0.00047	0.00102	CcSEcCtD
Doxepin—Weight increased—Epirubicin—sarcoma	0.000469	0.00102	CcSEcCtD
Doxepin—CYP1A2—liver—sarcoma	0.000468	0.00477	CbGeAlD
Doxepin—HTR2A—tendon—sarcoma	0.000468	0.00476	CbGeAlD
Doxepin—SLC6A2—lymph node—sarcoma	0.000467	0.00475	CbGeAlD
Doxepin—Dyspnoea—Etoposide—sarcoma	0.000466	0.00101	CcSEcCtD
Doxepin—Somnolence—Etoposide—sarcoma	0.000465	0.00101	CcSEcCtD
Doxepin—HRH1—testis—sarcoma	0.000464	0.00472	CbGeAlD
Doxepin—ABCB1—hematopoietic system—sarcoma	0.000463	0.00471	CbGeAlD
Doxepin—Hypersensitivity—Mitoxantrone—sarcoma	0.000463	0.00101	CcSEcCtD
Doxepin—Asthenia—Vincristine—sarcoma	0.000463	0.00101	CcSEcCtD
Doxepin—Vomiting—Thiotepa—sarcoma	0.000463	0.001	CcSEcCtD
Doxepin—Pneumonia—Epirubicin—sarcoma	0.000462	0.001	CcSEcCtD
Doxepin—Drowsiness—Epirubicin—sarcoma	0.00046	0.000997	CcSEcCtD
Doxepin—Infestation NOS—Epirubicin—sarcoma	0.00046	0.000997	CcSEcCtD
Doxepin—Infestation—Epirubicin—sarcoma	0.00046	0.000997	CcSEcCtD
Doxepin—Vomiting—Dactinomycin—sarcoma	0.000459	0.000997	CcSEcCtD
Doxepin—Rash—Thiotepa—sarcoma	0.000459	0.000996	CcSEcCtD
Doxepin—Bronchitis—Doxorubicin—sarcoma	0.000459	0.000996	CcSEcCtD
Doxepin—Dermatitis—Thiotepa—sarcoma	0.000459	0.000995	CcSEcCtD
Doxepin—Headache—Thiotepa—sarcoma	0.000456	0.00099	CcSEcCtD
Doxepin—ADRA2A—testis—sarcoma	0.000456	0.00464	CbGeAlD
Doxepin—Rash—Dactinomycin—sarcoma	0.000456	0.000989	CcSEcCtD
Doxepin—Decreased appetite—Etoposide—sarcoma	0.000455	0.000987	CcSEcCtD
Doxepin—Pancytopenia—Doxorubicin—sarcoma	0.000453	0.000983	CcSEcCtD
Doxepin—Gastrointestinal disorder—Etoposide—sarcoma	0.000452	0.00098	CcSEcCtD
Doxepin—Asthenia—Mitoxantrone—sarcoma	0.000451	0.000979	CcSEcCtD
Doxepin—Fatigue—Etoposide—sarcoma	0.000451	0.000978	CcSEcCtD
Doxepin—Neuropathy peripheral—Epirubicin—sarcoma	0.000451	0.000978	CcSEcCtD
Doxepin—Jaundice—Epirubicin—sarcoma	0.000448	0.000972	CcSEcCtD
Doxepin—Stomatitis—Epirubicin—sarcoma	0.000448	0.000972	CcSEcCtD
Doxepin—Pain—Etoposide—sarcoma	0.000447	0.000971	CcSEcCtD
Doxepin—Constipation—Etoposide—sarcoma	0.000447	0.000971	CcSEcCtD
Doxepin—Urinary tract infection—Epirubicin—sarcoma	0.000447	0.00097	CcSEcCtD
Doxepin—Dysuria—Doxorubicin—sarcoma	0.000446	0.000968	CcSEcCtD
Doxepin—CYP2C9—liver—sarcoma	0.000445	0.00452	CbGeAlD
Doxepin—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000443	0.000962	CcSEcCtD
Doxepin—Diarrhoea—Vincristine—sarcoma	0.000442	0.000959	CcSEcCtD
Doxepin—Sweating—Epirubicin—sarcoma	0.000441	0.000956	CcSEcCtD
Doxepin—Pollakiuria—Doxorubicin—sarcoma	0.000441	0.000956	CcSEcCtD
Doxepin—Hepatobiliary disease—Epirubicin—sarcoma	0.000435	0.000943	CcSEcCtD
Doxepin—Weight increased—Doxorubicin—sarcoma	0.000434	0.000942	CcSEcCtD
Doxepin—Nausea—Thiotepa—sarcoma	0.000432	0.000938	CcSEcCtD
Doxepin—Sinusitis—Epirubicin—sarcoma	0.000431	0.000936	CcSEcCtD
Doxepin—Feeling abnormal—Etoposide—sarcoma	0.000431	0.000935	CcSEcCtD
Doxepin—Diarrhoea—Mitoxantrone—sarcoma	0.00043	0.000934	CcSEcCtD
Doxepin—Nausea—Dactinomycin—sarcoma	0.000429	0.000931	CcSEcCtD
Doxepin—Agranulocytosis—Epirubicin—sarcoma	0.000429	0.000931	CcSEcCtD
Doxepin—Pneumonia—Doxorubicin—sarcoma	0.000428	0.000928	CcSEcCtD
Doxepin—Gastrointestinal pain—Etoposide—sarcoma	0.000428	0.000928	CcSEcCtD
Doxepin—Dizziness—Vincristine—sarcoma	0.000427	0.000926	CcSEcCtD
Doxepin—Infestation—Doxorubicin—sarcoma	0.000425	0.000923	CcSEcCtD
Doxepin—Infestation NOS—Doxorubicin—sarcoma	0.000425	0.000923	CcSEcCtD
Doxepin—Drowsiness—Doxorubicin—sarcoma	0.000425	0.000923	CcSEcCtD
Doxepin—Bradycardia—Epirubicin—sarcoma	0.00042	0.000912	CcSEcCtD
Doxepin—KCNH2—lymph node—sarcoma	0.00042	0.00427	CbGeAlD
Doxepin—Neuropathy peripheral—Doxorubicin—sarcoma	0.000417	0.000905	CcSEcCtD
Doxepin—Urticaria—Etoposide—sarcoma	0.000416	0.000902	CcSEcCtD
Doxepin—Jaundice—Doxorubicin—sarcoma	0.000415	0.0009	CcSEcCtD
Doxepin—Stomatitis—Doxorubicin—sarcoma	0.000415	0.0009	CcSEcCtD
Doxepin—ADRA2C—lymph node—sarcoma	0.000414	0.00421	CbGeAlD
Doxepin—Body temperature increased—Etoposide—sarcoma	0.000413	0.000897	CcSEcCtD
Doxepin—Abdominal pain—Etoposide—sarcoma	0.000413	0.000897	CcSEcCtD
Doxepin—Urinary tract infection—Doxorubicin—sarcoma	0.000413	0.000897	CcSEcCtD
Doxepin—Hepatitis—Epirubicin—sarcoma	0.000413	0.000895	CcSEcCtD
Doxepin—Hypoaesthesia—Epirubicin—sarcoma	0.000411	0.000891	CcSEcCtD
Doxepin—Vomiting—Vincristine—sarcoma	0.000411	0.000891	CcSEcCtD
Doxepin—Pharyngitis—Epirubicin—sarcoma	0.00041	0.000889	CcSEcCtD
Doxepin—Sweating—Doxorubicin—sarcoma	0.000408	0.000885	CcSEcCtD
Doxepin—Urinary tract disorder—Epirubicin—sarcoma	0.000408	0.000884	CcSEcCtD
Doxepin—Rash—Vincristine—sarcoma	0.000407	0.000883	CcSEcCtD
Doxepin—Dermatitis—Vincristine—sarcoma	0.000407	0.000883	CcSEcCtD
Doxepin—Oedema peripheral—Epirubicin—sarcoma	0.000407	0.000882	CcSEcCtD
Doxepin—Connective tissue disorder—Epirubicin—sarcoma	0.000406	0.00088	CcSEcCtD
Doxepin—Urethral disorder—Epirubicin—sarcoma	0.000405	0.000878	CcSEcCtD
Doxepin—Headache—Vincristine—sarcoma	0.000404	0.000878	CcSEcCtD
Doxepin—Hepatobiliary disease—Doxorubicin—sarcoma	0.000402	0.000873	CcSEcCtD
Doxepin—Vomiting—Mitoxantrone—sarcoma	0.0004	0.000868	CcSEcCtD
Doxepin—Sinusitis—Doxorubicin—sarcoma	0.000399	0.000866	CcSEcCtD
Doxepin—Agranulocytosis—Doxorubicin—sarcoma	0.000397	0.000861	CcSEcCtD
Doxepin—Rash—Mitoxantrone—sarcoma	0.000396	0.00086	CcSEcCtD
Doxepin—Dermatitis—Mitoxantrone—sarcoma	0.000396	0.00086	CcSEcCtD
Doxepin—Headache—Mitoxantrone—sarcoma	0.000394	0.000855	CcSEcCtD
Doxepin—Bradycardia—Doxorubicin—sarcoma	0.000389	0.000843	CcSEcCtD
Doxepin—HTR2A—testis—sarcoma	0.000387	0.00394	CbGeAlD
Doxepin—Eye disorder—Epirubicin—sarcoma	0.000386	0.000837	CcSEcCtD
Doxepin—Hypersensitivity—Etoposide—sarcoma	0.000385	0.000836	CcSEcCtD
Doxepin—Tinnitus—Epirubicin—sarcoma	0.000385	0.000835	CcSEcCtD
Doxepin—Nausea—Vincristine—sarcoma	0.000384	0.000832	CcSEcCtD
Doxepin—Cardiac disorder—Epirubicin—sarcoma	0.000383	0.000831	CcSEcCtD
Doxepin—Flushing—Epirubicin—sarcoma	0.000383	0.000831	CcSEcCtD
Doxepin—Hepatitis—Doxorubicin—sarcoma	0.000382	0.000829	CcSEcCtD
Doxepin—Hypoaesthesia—Doxorubicin—sarcoma	0.00038	0.000824	CcSEcCtD
Doxepin—Pharyngitis—Doxorubicin—sarcoma	0.000379	0.000822	CcSEcCtD
Doxepin—Urinary tract disorder—Doxorubicin—sarcoma	0.000377	0.000818	CcSEcCtD
Doxepin—Oedema peripheral—Doxorubicin—sarcoma	0.000376	0.000816	CcSEcCtD
Doxepin—Asthenia—Etoposide—sarcoma	0.000375	0.000814	CcSEcCtD
Doxepin—Connective tissue disorder—Doxorubicin—sarcoma	0.000375	0.000814	CcSEcCtD
Doxepin—Angiopathy—Epirubicin—sarcoma	0.000374	0.000812	CcSEcCtD
Doxepin—Urethral disorder—Doxorubicin—sarcoma	0.000374	0.000812	CcSEcCtD
Doxepin—Nausea—Mitoxantrone—sarcoma	0.000373	0.00081	CcSEcCtD
Doxepin—Immune system disorder—Epirubicin—sarcoma	0.000373	0.000809	CcSEcCtD
Doxepin—Mediastinal disorder—Epirubicin—sarcoma	0.000372	0.000807	CcSEcCtD
Doxepin—Chills—Epirubicin—sarcoma	0.00037	0.000803	CcSEcCtD
Doxepin—Pruritus—Etoposide—sarcoma	0.00037	0.000803	CcSEcCtD
Doxepin—Arrhythmia—Epirubicin—sarcoma	0.000369	0.0008	CcSEcCtD
Doxepin—HTR2A—liver—sarcoma	0.000366	0.00373	CbGeAlD
Doxepin—Alopecia—Epirubicin—sarcoma	0.000365	0.000791	CcSEcCtD
Doxepin—Mental disorder—Epirubicin—sarcoma	0.000362	0.000785	CcSEcCtD
Doxepin—Malnutrition—Epirubicin—sarcoma	0.000359	0.00078	CcSEcCtD
Doxepin—Erythema—Epirubicin—sarcoma	0.000359	0.00078	CcSEcCtD
Doxepin—Diarrhoea—Etoposide—sarcoma	0.000358	0.000777	CcSEcCtD
Doxepin—Eye disorder—Doxorubicin—sarcoma	0.000357	0.000774	CcSEcCtD
Doxepin—Tinnitus—Doxorubicin—sarcoma	0.000356	0.000773	CcSEcCtD
Doxepin—Cardiac disorder—Doxorubicin—sarcoma	0.000354	0.000769	CcSEcCtD
Doxepin—Flushing—Doxorubicin—sarcoma	0.000354	0.000769	CcSEcCtD
Doxepin—Flatulence—Epirubicin—sarcoma	0.000354	0.000768	CcSEcCtD
Doxepin—CYP2D6—testis—sarcoma	0.000353	0.00359	CbGeAlD
Doxepin—Tension—Epirubicin—sarcoma	0.000353	0.000765	CcSEcCtD
Doxepin—Dysgeusia—Epirubicin—sarcoma	0.000352	0.000763	CcSEcCtD
Doxepin—ABCB1—uterus—sarcoma	0.00035	0.00356	CbGeAlD
Doxepin—Nervousness—Epirubicin—sarcoma	0.000349	0.000757	CcSEcCtD
Doxepin—Back pain—Epirubicin—sarcoma	0.000347	0.000754	CcSEcCtD
Doxepin—Angiopathy—Doxorubicin—sarcoma	0.000346	0.000752	CcSEcCtD
Doxepin—Dizziness—Etoposide—sarcoma	0.000346	0.000751	CcSEcCtD
Doxepin—Muscle spasms—Epirubicin—sarcoma	0.000345	0.000749	CcSEcCtD
Doxepin—Immune system disorder—Doxorubicin—sarcoma	0.000345	0.000748	CcSEcCtD
Doxepin—Mediastinal disorder—Doxorubicin—sarcoma	0.000344	0.000747	CcSEcCtD
Doxepin—Chills—Doxorubicin—sarcoma	0.000343	0.000743	CcSEcCtD
Doxepin—Arrhythmia—Doxorubicin—sarcoma	0.000341	0.00074	CcSEcCtD
Doxepin—CYP3A4—liver—sarcoma	0.000339	0.00345	CbGeAlD
Doxepin—Vision blurred—Epirubicin—sarcoma	0.000339	0.000735	CcSEcCtD
Doxepin—Alopecia—Doxorubicin—sarcoma	0.000337	0.000732	CcSEcCtD
Doxepin—HRH1—lymph node—sarcoma	0.000336	0.00342	CbGeAlD
Doxepin—Mental disorder—Doxorubicin—sarcoma	0.000335	0.000726	CcSEcCtD
Doxepin—CYP2D6—liver—sarcoma	0.000334	0.00339	CbGeAlD
Doxepin—Ill-defined disorder—Epirubicin—sarcoma	0.000333	0.000723	CcSEcCtD
Doxepin—Vomiting—Etoposide—sarcoma	0.000333	0.000722	CcSEcCtD
Doxepin—Malnutrition—Doxorubicin—sarcoma	0.000332	0.000721	CcSEcCtD
Doxepin—Erythema—Doxorubicin—sarcoma	0.000332	0.000721	CcSEcCtD
Doxepin—Anaemia—Epirubicin—sarcoma	0.000332	0.00072	CcSEcCtD
Doxepin—ADRA2A—lymph node—sarcoma	0.00033	0.00336	CbGeAlD
Doxepin—Agitation—Epirubicin—sarcoma	0.00033	0.000716	CcSEcCtD
Doxepin—Rash—Etoposide—sarcoma	0.00033	0.000716	CcSEcCtD
Doxepin—Dermatitis—Etoposide—sarcoma	0.000329	0.000715	CcSEcCtD
Doxepin—Headache—Etoposide—sarcoma	0.000328	0.000711	CcSEcCtD
Doxepin—Flatulence—Doxorubicin—sarcoma	0.000328	0.000711	CcSEcCtD
Doxepin—ABCB1—lymphoid tissue—sarcoma	0.000326	0.00332	CbGeAlD
Doxepin—Tension—Doxorubicin—sarcoma	0.000326	0.000708	CcSEcCtD
Doxepin—Dysgeusia—Doxorubicin—sarcoma	0.000325	0.000706	CcSEcCtD
Doxepin—Malaise—Epirubicin—sarcoma	0.000324	0.000703	CcSEcCtD
Doxepin—Nervousness—Doxorubicin—sarcoma	0.000323	0.000701	CcSEcCtD
Doxepin—Vertigo—Epirubicin—sarcoma	0.000323	0.0007	CcSEcCtD
Doxepin—Syncope—Epirubicin—sarcoma	0.000322	0.000699	CcSEcCtD
Doxepin—Leukopenia—Epirubicin—sarcoma	0.000322	0.000698	CcSEcCtD
Doxepin—Back pain—Doxorubicin—sarcoma	0.000322	0.000698	CcSEcCtD
Doxepin—Muscle spasms—Doxorubicin—sarcoma	0.00032	0.000693	CcSEcCtD
Doxepin—Palpitations—Epirubicin—sarcoma	0.000317	0.000689	CcSEcCtD
Doxepin—Loss of consciousness—Epirubicin—sarcoma	0.000316	0.000685	CcSEcCtD
Doxepin—Cough—Epirubicin—sarcoma	0.000313	0.00068	CcSEcCtD
Doxepin—Vision blurred—Doxorubicin—sarcoma	0.000313	0.00068	CcSEcCtD
Doxepin—Convulsion—Epirubicin—sarcoma	0.000311	0.000675	CcSEcCtD
Doxepin—Nausea—Etoposide—sarcoma	0.000311	0.000674	CcSEcCtD
Doxepin—Hypertension—Epirubicin—sarcoma	0.00031	0.000673	CcSEcCtD
Doxepin—Ill-defined disorder—Doxorubicin—sarcoma	0.000308	0.000669	CcSEcCtD
Doxepin—Anaemia—Doxorubicin—sarcoma	0.000307	0.000667	CcSEcCtD
Doxepin—Myalgia—Epirubicin—sarcoma	0.000306	0.000664	CcSEcCtD
Doxepin—Chest pain—Epirubicin—sarcoma	0.000306	0.000664	CcSEcCtD
Doxepin—Arthralgia—Epirubicin—sarcoma	0.000306	0.000664	CcSEcCtD
Doxepin—Agitation—Doxorubicin—sarcoma	0.000305	0.000663	CcSEcCtD
Doxepin—Anxiety—Epirubicin—sarcoma	0.000305	0.000661	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000304	0.000659	CcSEcCtD
Doxepin—Discomfort—Epirubicin—sarcoma	0.000302	0.000656	CcSEcCtD
Doxepin—Malaise—Doxorubicin—sarcoma	0.0003	0.00065	CcSEcCtD
Doxepin—Dry mouth—Epirubicin—sarcoma	0.000299	0.000649	CcSEcCtD
Doxepin—Vertigo—Doxorubicin—sarcoma	0.000299	0.000648	CcSEcCtD
Doxepin—Syncope—Doxorubicin—sarcoma	0.000298	0.000647	CcSEcCtD
Doxepin—Leukopenia—Doxorubicin—sarcoma	0.000298	0.000646	CcSEcCtD
Doxepin—ABCB1—bone marrow—sarcoma	0.000297	0.00302	CbGeAlD
Doxepin—Confusional state—Epirubicin—sarcoma	0.000296	0.000641	CcSEcCtD
Doxepin—Palpitations—Doxorubicin—sarcoma	0.000294	0.000637	CcSEcCtD
Doxepin—Oedema—Epirubicin—sarcoma	0.000293	0.000636	CcSEcCtD
Doxepin—Loss of consciousness—Doxorubicin—sarcoma	0.000292	0.000634	CcSEcCtD
Doxepin—Infection—Epirubicin—sarcoma	0.000291	0.000632	CcSEcCtD
Doxepin—Cough—Doxorubicin—sarcoma	0.00029	0.000629	CcSEcCtD
Doxepin—Shock—Epirubicin—sarcoma	0.000288	0.000626	CcSEcCtD
Doxepin—Convulsion—Doxorubicin—sarcoma	0.000288	0.000625	CcSEcCtD
Doxepin—Nervous system disorder—Epirubicin—sarcoma	0.000288	0.000624	CcSEcCtD
Doxepin—Thrombocytopenia—Epirubicin—sarcoma	0.000287	0.000623	CcSEcCtD
Doxepin—Hypertension—Doxorubicin—sarcoma	0.000287	0.000623	CcSEcCtD
Doxepin—Tachycardia—Epirubicin—sarcoma	0.000286	0.000621	CcSEcCtD
Doxepin—Skin disorder—Epirubicin—sarcoma	0.000285	0.000618	CcSEcCtD
Doxepin—Hyperhidrosis—Epirubicin—sarcoma	0.000283	0.000615	CcSEcCtD
Doxepin—Arthralgia—Doxorubicin—sarcoma	0.000283	0.000614	CcSEcCtD
Doxepin—Myalgia—Doxorubicin—sarcoma	0.000283	0.000614	CcSEcCtD
Doxepin—Chest pain—Doxorubicin—sarcoma	0.000283	0.000614	CcSEcCtD
Doxepin—Anxiety—Doxorubicin—sarcoma	0.000282	0.000612	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000281	0.00061	CcSEcCtD
Doxepin—Discomfort—Doxorubicin—sarcoma	0.00028	0.000607	CcSEcCtD
Doxepin—Anorexia—Epirubicin—sarcoma	0.000279	0.000606	CcSEcCtD
Doxepin—Dry mouth—Doxorubicin—sarcoma	0.000277	0.000601	CcSEcCtD
Doxepin—Hypotension—Epirubicin—sarcoma	0.000274	0.000594	CcSEcCtD
Doxepin—Confusional state—Doxorubicin—sarcoma	0.000274	0.000594	CcSEcCtD
Doxepin—Oedema—Doxorubicin—sarcoma	0.000271	0.000589	CcSEcCtD
Doxepin—Infection—Doxorubicin—sarcoma	0.00027	0.000585	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000267	0.00058	CcSEcCtD
Doxepin—Shock—Doxorubicin—sarcoma	0.000267	0.000579	CcSEcCtD
Doxepin—Nervous system disorder—Doxorubicin—sarcoma	0.000266	0.000577	CcSEcCtD
Doxepin—Thrombocytopenia—Doxorubicin—sarcoma	0.000266	0.000576	CcSEcCtD
Doxepin—Insomnia—Epirubicin—sarcoma	0.000265	0.000575	CcSEcCtD
Doxepin—Tachycardia—Doxorubicin—sarcoma	0.000265	0.000575	CcSEcCtD
Doxepin—Skin disorder—Doxorubicin—sarcoma	0.000263	0.000572	CcSEcCtD
Doxepin—Paraesthesia—Epirubicin—sarcoma	0.000263	0.000571	CcSEcCtD
Doxepin—Hyperhidrosis—Doxorubicin—sarcoma	0.000262	0.000569	CcSEcCtD
Doxepin—Dyspnoea—Epirubicin—sarcoma	0.000261	0.000567	CcSEcCtD
Doxepin—Somnolence—Epirubicin—sarcoma	0.000261	0.000566	CcSEcCtD
Doxepin—Anorexia—Doxorubicin—sarcoma	0.000259	0.000561	CcSEcCtD
Doxepin—Dyspepsia—Epirubicin—sarcoma	0.000258	0.00056	CcSEcCtD
Doxepin—Decreased appetite—Epirubicin—sarcoma	0.000255	0.000553	CcSEcCtD
Doxepin—ABCB1—testis—sarcoma	0.000254	0.00258	CbGeAlD
Doxepin—Hypotension—Doxorubicin—sarcoma	0.000253	0.00055	CcSEcCtD
Doxepin—Gastrointestinal disorder—Epirubicin—sarcoma	0.000253	0.000549	CcSEcCtD
Doxepin—Fatigue—Epirubicin—sarcoma	0.000253	0.000548	CcSEcCtD
Doxepin—Pain—Epirubicin—sarcoma	0.000251	0.000544	CcSEcCtD
Doxepin—Constipation—Epirubicin—sarcoma	0.000251	0.000544	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000247	0.000536	CcSEcCtD
Doxepin—Insomnia—Doxorubicin—sarcoma	0.000245	0.000532	CcSEcCtD
Doxepin—Paraesthesia—Doxorubicin—sarcoma	0.000244	0.000529	CcSEcCtD
Doxepin—Dyspnoea—Doxorubicin—sarcoma	0.000242	0.000525	CcSEcCtD
Doxepin—Feeling abnormal—Epirubicin—sarcoma	0.000242	0.000524	CcSEcCtD
Doxepin—Somnolence—Doxorubicin—sarcoma	0.000241	0.000523	CcSEcCtD
Doxepin—ABCB1—liver—sarcoma	0.00024	0.00244	CbGeAlD
Doxepin—Gastrointestinal pain—Epirubicin—sarcoma	0.00024	0.00052	CcSEcCtD
Doxepin—Dyspepsia—Doxorubicin—sarcoma	0.000239	0.000518	CcSEcCtD
Doxepin—Decreased appetite—Doxorubicin—sarcoma	0.000236	0.000512	CcSEcCtD
Doxepin—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000234	0.000508	CcSEcCtD
Doxepin—Fatigue—Doxorubicin—sarcoma	0.000234	0.000508	CcSEcCtD
Doxepin—Urticaria—Epirubicin—sarcoma	0.000233	0.000505	CcSEcCtD
Doxepin—Pain—Doxorubicin—sarcoma	0.000232	0.000503	CcSEcCtD
Doxepin—Constipation—Doxorubicin—sarcoma	0.000232	0.000503	CcSEcCtD
Doxepin—Abdominal pain—Epirubicin—sarcoma	0.000232	0.000503	CcSEcCtD
Doxepin—Body temperature increased—Epirubicin—sarcoma	0.000232	0.000503	CcSEcCtD
Doxepin—Feeling abnormal—Doxorubicin—sarcoma	0.000224	0.000485	CcSEcCtD
Doxepin—Gastrointestinal pain—Doxorubicin—sarcoma	0.000222	0.000481	CcSEcCtD
Doxepin—Hypersensitivity—Epirubicin—sarcoma	0.000216	0.000469	CcSEcCtD
Doxepin—Urticaria—Doxorubicin—sarcoma	0.000216	0.000468	CcSEcCtD
Doxepin—Abdominal pain—Doxorubicin—sarcoma	0.000214	0.000465	CcSEcCtD
Doxepin—Body temperature increased—Doxorubicin—sarcoma	0.000214	0.000465	CcSEcCtD
Doxepin—Asthenia—Epirubicin—sarcoma	0.00021	0.000456	CcSEcCtD
Doxepin—Pruritus—Epirubicin—sarcoma	0.000207	0.00045	CcSEcCtD
Doxepin—Diarrhoea—Epirubicin—sarcoma	0.000201	0.000435	CcSEcCtD
Doxepin—Hypersensitivity—Doxorubicin—sarcoma	0.0002	0.000434	CcSEcCtD
Doxepin—Asthenia—Doxorubicin—sarcoma	0.000195	0.000422	CcSEcCtD
Doxepin—Dizziness—Epirubicin—sarcoma	0.000194	0.000421	CcSEcCtD
Doxepin—Pruritus—Doxorubicin—sarcoma	0.000192	0.000416	CcSEcCtD
Doxepin—Vomiting—Epirubicin—sarcoma	0.000186	0.000404	CcSEcCtD
Doxepin—Diarrhoea—Doxorubicin—sarcoma	0.000186	0.000403	CcSEcCtD
Doxepin—Rash—Epirubicin—sarcoma	0.000185	0.000401	CcSEcCtD
Doxepin—Dermatitis—Epirubicin—sarcoma	0.000185	0.000401	CcSEcCtD
Doxepin—ABCB1—lymph node—sarcoma	0.000184	0.00187	CbGeAlD
Doxepin—Headache—Epirubicin—sarcoma	0.000184	0.000399	CcSEcCtD
Doxepin—Dizziness—Doxorubicin—sarcoma	0.000179	0.000389	CcSEcCtD
Doxepin—Nausea—Epirubicin—sarcoma	0.000174	0.000378	CcSEcCtD
Doxepin—Vomiting—Doxorubicin—sarcoma	0.000172	0.000374	CcSEcCtD
Doxepin—Rash—Doxorubicin—sarcoma	0.000171	0.000371	CcSEcCtD
Doxepin—Dermatitis—Doxorubicin—sarcoma	0.000171	0.000371	CcSEcCtD
Doxepin—Headache—Doxorubicin—sarcoma	0.00017	0.000369	CcSEcCtD
Doxepin—Nausea—Doxorubicin—sarcoma	0.000161	0.00035	CcSEcCtD
Doxepin—ADRA2B—Signaling Pathways—MDM2—sarcoma	5.14e-06	0.00021	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CREB1—sarcoma	5.14e-06	0.00021	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—VEGFA—sarcoma	5.09e-06	0.000208	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—IL2—sarcoma	5.09e-06	0.000208	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CREB1—sarcoma	5.09e-06	0.000208	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CREB1—sarcoma	5.08e-06	0.000208	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—EGFR—sarcoma	5.04e-06	0.000206	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—NRAS—sarcoma	5.03e-06	0.000206	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—TP53—sarcoma	5.02e-06	0.000205	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—MDM2—sarcoma	4.96e-06	0.000203	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—CCND1—sarcoma	4.96e-06	0.000203	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—EGFR—sarcoma	4.96e-06	0.000203	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—KIT—sarcoma	4.95e-06	0.000203	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—NRAS—sarcoma	4.95e-06	0.000203	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—JUN—sarcoma	4.95e-06	0.000202	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—EGFR—sarcoma	4.95e-06	0.000202	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—MDM2—sarcoma	4.94e-06	0.000202	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—EGFR—sarcoma	4.94e-06	0.000202	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—SRC—sarcoma	4.93e-06	0.000202	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—EGFR—sarcoma	4.92e-06	0.000201	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—CTNNB1—sarcoma	4.91e-06	0.000201	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—EGFR—sarcoma	4.87e-06	0.000199	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—EGFR—sarcoma	4.86e-06	0.000199	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—VEGFA—sarcoma	4.8e-06	0.000196	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—MDM2—sarcoma	4.8e-06	0.000196	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—HRAS—sarcoma	4.8e-06	0.000196	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—HRAS—sarcoma	4.78e-06	0.000195	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—SRC—sarcoma	4.77e-06	0.000195	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—KRAS—sarcoma	4.76e-06	0.000195	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—NRAS—sarcoma	4.75e-06	0.000194	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—MDM2—sarcoma	4.73e-06	0.000193	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—SRC—sarcoma	4.72e-06	0.000193	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CREB1—sarcoma	4.72e-06	0.000193	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—KRAS—sarcoma	4.69e-06	0.000192	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—MYC—sarcoma	4.69e-06	0.000192	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—KRAS—sarcoma	4.68e-06	0.000191	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PLCG1—sarcoma	4.67e-06	0.000191	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—KRAS—sarcoma	4.66e-06	0.000191	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—VEGFA—sarcoma	4.65e-06	0.00019	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—KRAS—sarcoma	4.65e-06	0.00019	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—HRAS—sarcoma	4.61e-06	0.000189	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—KRAS—sarcoma	4.6e-06	0.000188	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—VEGFA—sarcoma	4.6e-06	0.000188	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—IL2—sarcoma	4.6e-06	0.000188	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—NRAS—sarcoma	4.59e-06	0.000188	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—KRAS—sarcoma	4.59e-06	0.000188	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—HRAS—sarcoma	4.59e-06	0.000188	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—EGFR—sarcoma	4.58e-06	0.000187	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—NRAS—sarcoma	4.54e-06	0.000186	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—EGFR—sarcoma	4.51e-06	0.000185	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—CCND1—sarcoma	4.48e-06	0.000183	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—JUN—sarcoma	4.47e-06	0.000183	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—HRAS—sarcoma	4.46e-06	0.000182	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—SRC—sarcoma	4.44e-06	0.000182	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—CTNNB1—sarcoma	4.44e-06	0.000181	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—IL2—sarcoma	4.44e-06	0.000181	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—MYC—sarcoma	4.42e-06	0.000181	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—IL2—sarcoma	4.41e-06	0.00018	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—HRAS—sarcoma	4.39e-06	0.00018	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MDM2—sarcoma	4.36e-06	0.000178	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—KRAS—sarcoma	4.33e-06	0.000177	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—VEGFA—sarcoma	4.33e-06	0.000177	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—CCND1—sarcoma	4.32e-06	0.000177	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—EGFR—sarcoma	4.32e-06	0.000177	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—JUN—sarcoma	4.32e-06	0.000176	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—CCND1—sarcoma	4.3e-06	0.000176	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—JUN—sarcoma	4.29e-06	0.000176	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—IL2—sarcoma	4.29e-06	0.000176	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MDM2—sarcoma	4.29e-06	0.000175	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—CTNNB1—sarcoma	4.28e-06	0.000175	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MDM2—sarcoma	4.28e-06	0.000175	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—MYC—sarcoma	4.28e-06	0.000175	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—NRAS—sarcoma	4.27e-06	0.000175	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MDM2—sarcoma	4.27e-06	0.000174	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—KRAS—sarcoma	4.26e-06	0.000174	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—CTNNB1—sarcoma	4.26e-06	0.000174	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MDM2—sarcoma	4.25e-06	0.000174	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—MYC—sarcoma	4.23e-06	0.000173	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—IL2—sarcoma	4.22e-06	0.000173	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MDM2—sarcoma	4.21e-06	0.000172	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MDM2—sarcoma	4.2e-06	0.000172	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—CCND1—sarcoma	4.18e-06	0.000171	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—EGFR—sarcoma	4.18e-06	0.000171	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—JUN—sarcoma	4.18e-06	0.000171	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—CTNNB1—sarcoma	4.14e-06	0.000169	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—EGFR—sarcoma	4.14e-06	0.000169	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CCND1—sarcoma	4.12e-06	0.000168	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—JUN—sarcoma	4.11e-06	0.000168	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—KRAS—sarcoma	4.08e-06	0.000167	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CTNNB1—sarcoma	4.08e-06	0.000167	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—HRAS—sarcoma	4.05e-06	0.000166	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—SRC—sarcoma	4.01e-06	0.000164	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—HRAS—sarcoma	3.98e-06	0.000163	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—MYC—sarcoma	3.98e-06	0.000163	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—HRAS—sarcoma	3.98e-06	0.000163	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—HRAS—sarcoma	3.96e-06	0.000162	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—KRAS—sarcoma	3.95e-06	0.000162	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—HRAS—sarcoma	3.95e-06	0.000162	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—HRAS—sarcoma	3.91e-06	0.00016	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—KRAS—sarcoma	3.91e-06	0.00016	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—VEGFA—sarcoma	3.91e-06	0.00016	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MDM2—sarcoma	3.9e-06	0.00016	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—HRAS—sarcoma	3.9e-06	0.00016	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—IL2—sarcoma	3.89e-06	0.000159	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—EGFR—sarcoma	3.89e-06	0.000159	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—SRC—sarcoma	3.87e-06	0.000158	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—NRAS—sarcoma	3.86e-06	0.000158	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—SRC—sarcoma	3.85e-06	0.000157	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—TP53—sarcoma	3.85e-06	0.000157	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—IL2—sarcoma	3.83e-06	0.000157	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—IL2—sarcoma	3.82e-06	0.000156	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—IL2—sarcoma	3.81e-06	0.000156	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—IL2—sarcoma	3.8e-06	0.000155	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CCND1—sarcoma	3.8e-06	0.000155	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—JUN—sarcoma	3.79e-06	0.000155	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—VEGFA—sarcoma	3.77e-06	0.000154	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—IL2—sarcoma	3.76e-06	0.000154	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CTNNB1—sarcoma	3.76e-06	0.000154	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—IL2—sarcoma	3.75e-06	0.000153	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—VEGFA—sarcoma	3.75e-06	0.000153	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—SRC—sarcoma	3.75e-06	0.000153	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CCND1—sarcoma	3.74e-06	0.000153	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—JUN—sarcoma	3.73e-06	0.000152	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CCND1—sarcoma	3.73e-06	0.000152	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—NRAS—sarcoma	3.72e-06	0.000152	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—JUN—sarcoma	3.72e-06	0.000152	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CCND1—sarcoma	3.72e-06	0.000152	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—JUN—sarcoma	3.71e-06	0.000152	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—NRAS—sarcoma	3.7e-06	0.000152	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CCND1—sarcoma	3.7e-06	0.000151	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CTNNB1—sarcoma	3.7e-06	0.000151	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—JUN—sarcoma	3.7e-06	0.000151	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CTNNB1—sarcoma	3.69e-06	0.000151	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—SRC—sarcoma	3.69e-06	0.000151	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—HRAS—sarcoma	3.68e-06	0.000151	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CTNNB1—sarcoma	3.68e-06	0.00015	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—KRAS—sarcoma	3.68e-06	0.00015	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CTNNB1—sarcoma	3.67e-06	0.00015	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CCND1—sarcoma	3.67e-06	0.00015	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—JUN—sarcoma	3.66e-06	0.00015	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CCND1—sarcoma	3.66e-06	0.00015	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—JUN—sarcoma	3.65e-06	0.000149	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—VEGFA—sarcoma	3.65e-06	0.000149	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CTNNB1—sarcoma	3.63e-06	0.000149	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—TP53—sarcoma	3.63e-06	0.000148	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—HRAS—sarcoma	3.62e-06	0.000148	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CTNNB1—sarcoma	3.62e-06	0.000148	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—NRAS—sarcoma	3.6e-06	0.000147	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—MYC—sarcoma	3.59e-06	0.000147	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—VEGFA—sarcoma	3.59e-06	0.000147	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—NRAS—sarcoma	3.55e-06	0.000145	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—EGFR—sarcoma	3.51e-06	0.000144	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—TP53—sarcoma	3.51e-06	0.000144	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—IL2—sarcoma	3.49e-06	0.000143	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—TP53—sarcoma	3.48e-06	0.000142	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—HRAS—sarcoma	3.47e-06	0.000142	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—MYC—sarcoma	3.47e-06	0.000142	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—MYC—sarcoma	3.45e-06	0.000141	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CCND1—sarcoma	3.4e-06	0.000139	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—SRC—sarcoma	3.4e-06	0.000139	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—EGFR—sarcoma	3.39e-06	0.000139	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—JUN—sarcoma	3.39e-06	0.000139	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—EGFR—sarcoma	3.38e-06	0.000138	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CTNNB1—sarcoma	3.37e-06	0.000138	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—HRAS—sarcoma	3.36e-06	0.000137	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—MYC—sarcoma	3.36e-06	0.000137	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—SRC—sarcoma	3.34e-06	0.000137	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—SRC—sarcoma	3.34e-06	0.000136	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—SRC—sarcoma	3.33e-06	0.000136	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—HRAS—sarcoma	3.32e-06	0.000136	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—KRAS—sarcoma	3.32e-06	0.000136	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—SRC—sarcoma	3.32e-06	0.000136	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—VEGFA—sarcoma	3.31e-06	0.000135	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—MYC—sarcoma	3.3e-06	0.000135	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—SRC—sarcoma	3.28e-06	0.000134	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—EGFR—sarcoma	3.28e-06	0.000134	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—SRC—sarcoma	3.27e-06	0.000134	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—NRAS—sarcoma	3.27e-06	0.000134	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—TP53—sarcoma	3.27e-06	0.000134	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—VEGFA—sarcoma	3.26e-06	0.000133	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—VEGFA—sarcoma	3.25e-06	0.000133	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—VEGFA—sarcoma	3.24e-06	0.000132	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—EGFR—sarcoma	3.23e-06	0.000132	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—VEGFA—sarcoma	3.23e-06	0.000132	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—NRAS—sarcoma	3.22e-06	0.000132	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—NRAS—sarcoma	3.21e-06	0.000131	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—KRAS—sarcoma	3.21e-06	0.000131	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—NRAS—sarcoma	3.2e-06	0.000131	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—VEGFA—sarcoma	3.2e-06	0.000131	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—NRAS—sarcoma	3.19e-06	0.00013	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—VEGFA—sarcoma	3.19e-06	0.00013	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—KRAS—sarcoma	3.19e-06	0.00013	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—NRAS—sarcoma	3.16e-06	0.000129	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—NRAS—sarcoma	3.15e-06	0.000129	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—HRAS—sarcoma	3.13e-06	0.000128	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—KRAS—sarcoma	3.1e-06	0.000127	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—KRAS—sarcoma	3.05e-06	0.000125	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MYC—sarcoma	3.05e-06	0.000125	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—SRC—sarcoma	3.04e-06	0.000124	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MYC—sarcoma	3e-06	0.000123	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MYC—sarcoma	2.99e-06	0.000122	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MYC—sarcoma	2.98e-06	0.000122	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—EGFR—sarcoma	2.98e-06	0.000122	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MYC—sarcoma	2.97e-06	0.000122	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—VEGFA—sarcoma	2.96e-06	0.000121	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—TP53—sarcoma	2.95e-06	0.000121	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MYC—sarcoma	2.94e-06	0.00012	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MYC—sarcoma	2.93e-06	0.00012	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—EGFR—sarcoma	2.93e-06	0.00012	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—NRAS—sarcoma	2.93e-06	0.00012	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—EGFR—sarcoma	2.92e-06	0.00012	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—EGFR—sarcoma	2.92e-06	0.000119	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—EGFR—sarcoma	2.91e-06	0.000119	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—EGFR—sarcoma	2.88e-06	0.000118	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—EGFR—sarcoma	2.87e-06	0.000117	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—TP53—sarcoma	2.85e-06	0.000116	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—TP53—sarcoma	2.83e-06	0.000116	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—HRAS—sarcoma	2.82e-06	0.000115	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—KRAS—sarcoma	2.81e-06	0.000115	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—KRAS—sarcoma	2.77e-06	0.000113	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—KRAS—sarcoma	2.76e-06	0.000113	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—TP53—sarcoma	2.76e-06	0.000113	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—KRAS—sarcoma	2.75e-06	0.000113	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—KRAS—sarcoma	2.75e-06	0.000112	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MYC—sarcoma	2.73e-06	0.000111	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—HRAS—sarcoma	2.72e-06	0.000111	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—KRAS—sarcoma	2.72e-06	0.000111	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—TP53—sarcoma	2.71e-06	0.000111	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—KRAS—sarcoma	2.71e-06	0.000111	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—HRAS—sarcoma	2.71e-06	0.000111	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—EGFR—sarcoma	2.67e-06	0.000109	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—HRAS—sarcoma	2.64e-06	0.000108	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—HRAS—sarcoma	2.59e-06	0.000106	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—KRAS—sarcoma	2.52e-06	0.000103	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—TP53—sarcoma	2.5e-06	0.000102	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—TP53—sarcoma	2.46e-06	0.000101	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—TP53—sarcoma	2.46e-06	0.0001	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—TP53—sarcoma	2.45e-06	0.0001	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—TP53—sarcoma	2.44e-06	9.98e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—TP53—sarcoma	2.42e-06	9.88e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—TP53—sarcoma	2.41e-06	9.85e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—HRAS—sarcoma	2.39e-06	9.78e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—HRAS—sarcoma	2.35e-06	9.62e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—HRAS—sarcoma	2.35e-06	9.6e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—HRAS—sarcoma	2.34e-06	9.57e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—HRAS—sarcoma	2.33e-06	9.54e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—HRAS—sarcoma	2.31e-06	9.45e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—HRAS—sarcoma	2.3e-06	9.42e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—TP53—sarcoma	2.24e-06	9.16e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—HRAS—sarcoma	2.14e-06	8.76e-05	CbGpPWpGaD
